GENEVIEVE PROTOCOL
Live / Registered — Registered and renewed (as of 09 Sept 2019)
What this means for you
Registered since 28 Jul 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Jul 2019).
Record
- Serial number
- 77389950
- Registration number
- 3661647
- Mark type
- Stylized text
- Filed
- 06 Feb 2008
- Published for opposition
- 08 Jul 2008
- Registered
- 28 Jul 2009
- Next maintenance due
- 28 Jul 2019
- Attorney of record
- Jean L. Batman
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical services featuring a clinical protocol wherein two distinct tumor-targeted gene vectors, one carrying a cytocidal gene (a mutated cyclin G1), and the other bearing an immunomodulatory cytokine gene (GM-CSF), are used in combination for cancer immunotherapy or cancer vaccination
Owner
- GENVIVO, INC., SAN MARINO, CA, US
- Epeius Biotechnologies Corporation, San Marino, CA, US
- Epeius Biotechnologies Corporation, San Marino, CA, US
- Epeius Biotechnologies Corporation, San Marino, CA, US
Prosecution history
- 09 Sept 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Sept 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Sept 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 06 Sept 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Jul 2019 — TEAS SECTION 8 & 9 RECEIVED
- 30 Jan 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 Jul 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Dec 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Dec 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Dec 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Nov 2014 — TEAS SECTION 8 & 15 RECEIVED
- 28 Jul 2009 — REGISTERED-PRINCIPAL REGISTER
- 23 Jun 2009 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 17 Jun 2009 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jun 2009 — TEAS/EMAIL CORRESPONDENCE ENTERED